aclacinomycin has been researched along with neothramycins in 2 studies
| Studies (aclacinomycin) | Trials (aclacinomycin) | Recent Studies (post-2010) (aclacinomycin) | Studies (neothramycins) | Trials (neothramycins) | Recent Studies (post-2010) (neothramycins) |
|---|---|---|---|---|---|
| 168 | 8 | 21 | 15 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, K; Turk, JL | 1 |
| Ishizuka, M | 1 |
2 other study(ies) available for aclacinomycin and neothramycins
| Article | Year |
|---|---|
Effect of anticancer agents neothramycin, aclacinomycin, FK-565 and FK-156 on the release of interleukin-2 and interleukin-1 in vitro.
Topics: Aclarubicin; Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Benzodiazepinones; Diaminopimelic Acid; Dose-Response Relationship, Immunologic; Interleukin-1; Interleukin-2; Male; Oligopeptides; Rats; Rats, Inbred Lew; Spleen | 1989 |
[Immunomodulation by antitumor antibiotics].
Topics: Aclarubicin; Animals; Anthramycin; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Benzodiazepinones; Guanidines; Immune Tolerance; Leukemia L1210; Mice; Naphthacenes; Peptides; Ribonucleosides | 1986 |